Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for ELK4_ETV5_ELK1_ELK3_ELF4
Z-value: 2.69
Motif logo
Transcription factors associated with ELK4_ETV5_ELK1_ELK3_ELF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELK4
|
ENSG00000158711.9 | ETS transcription factor ELK4 |
|
ETV5
|
ENSG00000244405.3 | ETS variant transcription factor 5 |
|
ELK1
|
ENSG00000126767.13 | ETS transcription factor ELK1 |
|
ELK3
|
ENSG00000111145.3 | ETS transcription factor ELK3 |
|
ELF4
|
ENSG00000102034.12 | E74 like ETS transcription factor 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ETV5 | hg19_v2_chr3_-_185826855_185826911 | 0.93 | 5.1e-09 | Click! |
| ELK1 | hg19_v2_chrX_-_47509994_47510008 | 0.54 | 1.4e-02 | Click! |
| ELF4 | hg19_v2_chrX_-_129244655_129244697 | -0.46 | 4.3e-02 | Click! |
| ELK4 | hg19_v2_chr1_-_205601064_205601090 | -0.38 | 9.6e-02 | Click! |
| ELK3 | hg19_v2_chr12_+_96588143_96588185 | -0.28 | 2.4e-01 | Click! |
Activity profile of ELK4_ETV5_ELK1_ELK3_ELF4 motif
Sorted Z-values of ELK4_ETV5_ELK1_ELK3_ELF4 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ELK4_ETV5_ELK1_ELK3_ELF4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 29.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 4.2 | 20.9 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 3.8 | 7.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 3.7 | 18.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 3.5 | 14.0 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 3.4 | 3.4 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 3.1 | 9.2 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 2.9 | 11.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 2.9 | 23.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 2.8 | 8.4 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 2.5 | 12.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 2.5 | 7.5 | GO:0046680 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 2.4 | 7.3 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 2.4 | 16.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 2.4 | 9.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.1 | 6.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 2.1 | 14.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.1 | 16.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.0 | 8.1 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 2.0 | 2.0 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 2.0 | 5.9 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 1.9 | 11.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 1.9 | 22.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.9 | 7.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.8 | 9.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.8 | 5.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 1.8 | 10.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.7 | 6.9 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
| 1.7 | 5.0 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.7 | 18.4 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 1.6 | 9.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.6 | 17.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.6 | 6.5 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.6 | 6.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 1.6 | 8.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 1.6 | 17.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.6 | 9.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.6 | 6.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 1.5 | 9.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.5 | 4.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 1.5 | 7.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 1.5 | 5.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.4 | 5.7 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 1.4 | 4.2 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.3 | 6.7 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 1.3 | 2.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
| 1.3 | 3.9 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 1.3 | 1.3 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 1.3 | 6.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.3 | 3.8 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.2 | 6.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.2 | 2.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 1.2 | 6.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 1.2 | 24.3 | GO:0031167 | rRNA methylation(GO:0031167) |
| 1.2 | 4.8 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 1.2 | 7.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 1.1 | 2.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 1.1 | 11.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.1 | 3.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 1.1 | 4.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 1.1 | 3.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.1 | 6.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.1 | 17.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.1 | 3.2 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.1 | 4.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 | 2.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.0 | 6.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.0 | 1.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.0 | 2.0 | GO:0033280 | response to vitamin D(GO:0033280) cellular response to vitamin D(GO:0071305) |
| 1.0 | 5.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 | 3.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 1.0 | 3.0 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.0 | 9.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 1.0 | 3.9 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.0 | 4.9 | GO:0032218 | riboflavin transport(GO:0032218) |
| 1.0 | 2.9 | GO:0019085 | early viral transcription(GO:0019085) |
| 1.0 | 3.9 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 1.0 | 1.0 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 1.0 | 7.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.0 | 21.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.9 | 7.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.9 | 3.8 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.9 | 2.8 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.9 | 25.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.9 | 2.8 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.9 | 10.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.9 | 1.8 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.9 | 3.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.9 | 4.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.9 | 10.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.9 | 5.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.9 | 8.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.9 | 3.5 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.9 | 37.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.9 | 2.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.9 | 6.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.9 | 3.5 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.9 | 3.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.9 | 2.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.9 | 3.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.9 | 2.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.8 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.8 | 7.4 | GO:0046618 | drug export(GO:0046618) |
| 0.8 | 23.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.8 | 47.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.8 | 4.8 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.8 | 6.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.8 | 3.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.8 | 0.8 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.8 | 9.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.8 | 2.3 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.8 | 3.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.8 | 8.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to ciliary membrane(GO:1903441) |
| 0.8 | 9.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.7 | 14.9 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.7 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.7 | 6.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.7 | 5.9 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.7 | 3.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.7 | 12.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.7 | 5.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.7 | 2.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.7 | 1.4 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.7 | 6.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.7 | 6.1 | GO:0007135 | meiosis II(GO:0007135) |
| 0.7 | 2.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.7 | 4.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.7 | 4.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.7 | 12.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.7 | 1.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.7 | 4.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.7 | 2.6 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.7 | 2.6 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.7 | 5.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.6 | 3.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.6 | 6.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.6 | 3.9 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.6 | 0.6 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.6 | 2.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.6 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.6 | 2.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.6 | 4.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.6 | 3.7 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.6 | 2.5 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.6 | 5.5 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.6 | 0.6 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.6 | 2.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.6 | 3.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.6 | 3.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.6 | 7.9 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.6 | 6.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.6 | 1.8 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.6 | 3.6 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.6 | 0.6 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.6 | 4.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.6 | 11.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.6 | 5.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.6 | 2.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 | 2.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.6 | 1.7 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.6 | 2.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.6 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.6 | 1.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.6 | 1.7 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.6 | 2.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.6 | 2.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.6 | 1.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.6 | 7.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.6 | 3.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.6 | 11.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.6 | 1.7 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.6 | 12.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.6 | 5.0 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.5 | 1.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.5 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.5 | 1.6 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.5 | 4.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 | 3.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 | 1.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.5 | 2.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.5 | 4.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.5 | 1.6 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 0.5 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.5 | 0.5 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.5 | 5.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.5 | 3.2 | GO:0030047 | actin modification(GO:0030047) |
| 0.5 | 31.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.5 | 2.6 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.5 | 0.5 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.5 | 1.6 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.5 | 3.2 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.5 | 2.1 | GO:1901804 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.5 | 2.1 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.5 | 9.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.5 | 1.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.5 | 2.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.5 | 5.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.5 | 2.6 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.5 | 2.6 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.5 | 2.0 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.5 | 0.5 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.5 | 5.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
| 0.5 | 8.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.5 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.5 | 1.0 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.5 | 3.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.5 | 11.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.5 | 1.5 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.5 | 3.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 | 2.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.5 | 0.5 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.5 | 4.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.5 | 3.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.5 | 3.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.5 | 1.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.5 | 2.4 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.5 | 1.0 | GO:0015816 | glycine transport(GO:0015816) |
| 0.5 | 1.9 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.5 | 1.0 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.5 | 1.0 | GO:0043010 | camera-type eye development(GO:0043010) |
| 0.5 | 2.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.5 | 6.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.5 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.5 | 4.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.5 | 1.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.5 | 6.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.5 | 2.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.5 | 0.9 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.5 | 0.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 | 10.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.5 | 3.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.5 | 2.3 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.5 | 2.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.4 | 9.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.4 | 2.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 1.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.4 | 11.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.4 | 1.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.4 | 2.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.4 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.4 | 2.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.4 | 24.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 | 3.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 1.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.4 | 1.3 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.4 | 1.7 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.4 | 0.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.4 | 1.3 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.4 | 3.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.4 | 0.9 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.4 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.4 | 3.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.4 | 1.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 | 3.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.4 | 0.4 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.4 | 2.1 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.4 | 1.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.4 | 10.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 | 2.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 | 3.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.4 | 1.2 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.4 | 1.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.4 | 7.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.4 | 2.0 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.4 | 4.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.4 | 3.7 | GO:0030242 | pexophagy(GO:0030242) |
| 0.4 | 2.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 | 1.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.4 | 0.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.4 | 6.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.4 | 1.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.4 | 2.8 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.4 | 4.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.4 | 0.4 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
| 0.4 | 2.4 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.4 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 1.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 | 28.0 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.4 | 2.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.4 | 2.3 | GO:0042262 | DNA protection(GO:0042262) |
| 0.4 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.4 | 1.2 | GO:1900738 | dense core granule biogenesis(GO:0061110) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
| 0.4 | 1.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.4 | 2.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.4 | 6.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 | 1.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.4 | 1.5 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.4 | 0.8 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.4 | 3.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.4 | 1.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 1.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 3.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 | 1.5 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.4 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.4 | 7.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.4 | 1.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.4 | 1.1 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.4 | 9.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.4 | 2.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.4 | 1.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.4 | 6.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 2.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 | 0.4 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.4 | 2.9 | GO:0033504 | floor plate development(GO:0033504) |
| 0.4 | 1.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.4 | 2.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 1.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 | 3.9 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.4 | 7.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.3 | 13.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.3 | 2.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 1.4 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.3 | 2.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 10.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.3 | 1.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.3 | 4.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 0.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 | 4.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 | 1.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.3 | 17.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.3 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 5.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 7.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 0.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 3.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.3 | 3.7 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.3 | 1.3 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 | 2.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.3 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.3 | 0.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.3 | 7.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.3 | 1.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.3 | 37.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.3 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.3 | 1.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 1.3 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.3 | 1.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.3 | 0.3 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.3 | 3.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.3 | 6.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 0.6 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.3 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 | 1.3 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 2.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 1.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.3 | 1.2 | GO:0006550 | isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 0.3 | 1.9 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 | 1.6 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.3 | 0.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.3 | 0.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.3 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.3 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.3 | 2.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 3.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.3 | 0.9 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.3 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.3 | 27.2 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.3 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.3 | 1.2 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 1.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 | 1.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 | 1.2 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.3 | 2.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 1.8 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.3 | 0.6 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.3 | 3.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 0.9 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.3 | 1.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 8.8 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 0.9 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.3 | 0.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 | 0.6 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.3 | 0.3 | GO:0051491 | regulation of filopodium assembly(GO:0051489) positive regulation of filopodium assembly(GO:0051491) |
| 0.3 | 1.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 2.6 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.3 | 2.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 2.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 | 2.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.3 | 1.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 0.6 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 0.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
| 0.3 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.3 | 1.4 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 0.6 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.3 | 2.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 1.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.3 | 0.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.3 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 | 1.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 3.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 0.6 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 0.3 | 0.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.3 | 4.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.3 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
| 0.3 | 5.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 3.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 | 2.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 1.3 | GO:0097102 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.3 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.3 | 1.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.3 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 | 1.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.3 | 2.1 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.3 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.3 | 0.8 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.3 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 | 2.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.3 | 6.4 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.3 | 0.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 | 0.8 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.3 | 6.4 | GO:0043574 | peroxisomal transport(GO:0043574) |
| 0.3 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.3 | 1.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 0.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.3 | 10.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 0.5 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.3 | 1.3 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.3 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 | 3.0 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.3 | 1.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.2 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.5 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.2 | 1.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 | 0.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.2 | 1.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 3.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 | 2.4 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.2 | 2.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 | 5.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 | 0.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 27.0 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.2 | 8.6 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 0.2 | 4.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 1.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.2 | 0.9 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.2 | 2.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.2 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.2 | 0.9 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.2 | 0.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 | 2.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 | 1.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 0.5 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 1.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 1.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 1.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.2 | 1.1 | GO:0072641 | type I interferon secretion(GO:0072641) |
| 0.2 | 4.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 1.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.2 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 2.2 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.2 | 0.9 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.2 | 0.9 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.2 | 3.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.2 | 1.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.2 | 3.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 3.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 1.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.2 | 3.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.2 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.2 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 2.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.2 | 2.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.2 | 1.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 | 1.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 0.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.2 | 2.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.2 | 0.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 0.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.2 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.2 | 0.8 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 0.4 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.2 | 1.3 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.2 | 0.2 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.2 | 30.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.2 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.2 | 0.6 | GO:0061571 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.2 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 2.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 0.8 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.2 | 6.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 | 0.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.2 | 0.6 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
| 0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
| 0.2 | 1.4 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 0.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.2 | 2.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 | 1.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 1.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.2 | 4.0 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 0.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.2 | 1.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 | 0.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 2.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 | 0.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.2 | 25.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.2 | 0.4 | GO:1900138 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 3.3 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 1.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.2 | 1.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 | 5.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 1.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 0.6 | GO:0018011 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 2.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 6.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 0.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.2 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.2 | 0.7 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.2 | 0.7 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 | 1.3 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.2 | 3.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.2 | 0.7 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 1.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.2 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.2 | 0.9 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 0.2 | 1.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 1.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 0.7 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 0.9 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 3.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 2.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 1.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 3.8 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.2 | 1.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 1.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 0.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.2 | 0.5 | GO:1904617 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.2 | 1.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 1.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 | 0.5 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 0.2 | 1.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.2 | 2.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.2 | 0.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.2 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 2.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 0.7 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 0.5 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.2 | 5.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.5 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 | 0.7 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 2.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.2 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 0.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 2.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 0.7 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.2 | 0.7 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 | 0.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.7 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.2 | 0.5 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 | 4.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 1.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.2 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
| 0.2 | 4.8 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.2 | 1.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.2 | 2.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.2 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.2 | 5.9 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.2 | 0.3 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.2 | 6.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 0.6 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 0.8 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.2 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 0.6 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.2 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.2 | 0.2 | GO:0007051 | spindle organization(GO:0007051) |
| 0.2 | 1.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 9.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.2 | 1.8 | GO:0015866 | ADP transport(GO:0015866) |
| 0.2 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 1.1 | GO:0046137 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.2 | 3.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 1.1 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 | 1.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.2 | 0.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.3 | GO:2001186 | regulation of T cell antigen processing and presentation(GO:0002625) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 0.3 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.1 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.1 | 1.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 | 0.7 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.1 | 5.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.1 | 0.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 5.3 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 3.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 | 0.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.1 | 0.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 9.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.6 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.1 | 1.1 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 2.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 2.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 0.3 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.1 | 1.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 2.4 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 2.5 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.1 | 3.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 2.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 0.1 | GO:2000584 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.1 | 0.7 | GO:0030111 | regulation of Wnt signaling pathway(GO:0030111) |
| 0.1 | 1.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.1 | 0.3 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.4 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) late nucleophagy(GO:0044805) |
| 0.1 | 1.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 2.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
| 0.1 | 0.4 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.5 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
| 0.1 | 2.3 | GO:0043578 | nuclear matrix organization(GO:0043578) |
| 0.1 | 0.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 1.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.7 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.1 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
| 0.1 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
| 0.1 | 1.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 | 5.2 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.1 | 1.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 1.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 1.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.1 | 1.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 | 5.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 3.2 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 1.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.1 | 0.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 | 1.3 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 1.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 | 1.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 | 5.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 | 1.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.1 | 2.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 0.5 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.1 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 | 2.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 | 1.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 4.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 2.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 1.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.1 | 4.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 1.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 4.7 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 1.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.1 | 0.6 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.1 | 1.7 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 | 0.7 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
| 0.1 | 0.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 0.1 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.9 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.1 | 0.8 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 12.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.1 | 3.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 0.5 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.1 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 5.8 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 | 0.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 0.1 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 | 0.2 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.1 | 9.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.1 | 0.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.7 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 | 1.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 1.0 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
| 0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 | 1.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 3.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.6 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.1 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 2.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.2 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.1 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.9 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.1 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 1.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.1 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.1 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 1.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
| 0.1 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.1 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.2 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 | 0.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.1 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.1 | 1.4 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 2.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.1 | 1.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 8.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 1.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 | 0.5 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.1 | 0.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 | 4.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.1 | 0.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.1 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.1 | 0.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.5 | GO:0009838 | abscission(GO:0009838) |
| 0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.1 | 0.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.1 | 1.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.7 | GO:0015677 | copper ion import(GO:0015677) |
| 0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.1 | 1.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
| 0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 | 0.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.1 | 0.3 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 0.1 | 0.3 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 | 1.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.1 | 3.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) positive regulation of stem cell proliferation(GO:2000648) |
| 0.1 | 3.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 7.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.1 | 1.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 0.4 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) |
| 0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 7.8 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.1 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.2 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 | 1.9 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 2.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 3.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 | 0.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 2.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.1 | 0.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.1 | 3.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.1 | 0.4 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.1 | 0.9 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 3.1 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.6 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 3.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 | 0.5 | GO:0048806 | genitalia development(GO:0048806) |
| 0.1 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 1.3 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.1 | 0.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 0.7 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.5 | GO:0097491 | sympathetic ganglion development(GO:0061549) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.1 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 1.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 | 0.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.5 | GO:0043269 | regulation of ion transport(GO:0043269) |
| 0.1 | 1.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 2.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.1 | 0.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 | 1.1 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.1 | 0.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 1.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.1 | 0.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.1 | 0.1 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 | 0.2 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 1.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.1 | 0.5 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.1 | 1.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.1 | 0.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.3 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.1 | 0.6 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 1.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 1.3 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 | 0.8 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.1 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.1 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.1 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 1.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 0.8 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 1.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 0.4 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 0.1 | 0.2 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
| 0.1 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 1.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.5 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.1 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.1 | 0.6 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.1 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 | 0.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.1 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 2.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 | 0.6 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 1.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.2 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.1 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 0.1 | 0.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.8 | GO:0002924 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.1 | 0.2 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.1 | 0.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.1 | 0.5 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
| 0.1 | 0.2 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 0.4 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.4 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
| 0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.1 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 0.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
| 0.0 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.0 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.0 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
| 0.0 | 0.1 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 | 0.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 | 2.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.0 | 0.3 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.0 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.0 | 0.9 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.0 | 1.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.0 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.0 | 0.3 | GO:1900364 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.0 | 0.6 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.0 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 | 0.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) thiamine-containing compound metabolic process(GO:0042723) |
| 0.0 | 0.7 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.0 | 0.3 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.0 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.2 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.0 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.0 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.0 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.0 | 1.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 3.6 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
| 0.0 | 0.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 0.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.2 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
| 0.0 | 0.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 1.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 | 0.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 0.0 | GO:0051054 | positive regulation of DNA metabolic process(GO:0051054) |
| 0.0 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 | 0.2 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.0 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.0 | 0.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.9 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
| 0.0 | 0.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 | 0.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
| 0.0 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.0 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.1 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.0 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 | 0.2 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 | 1.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 0.1 | GO:0050894 | determination of affect(GO:0050894) |
| 0.0 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 | 0.5 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.0 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.0 | 0.2 | GO:0018199 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
| 0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.0 | 0.1 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 | 0.2 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.0 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) membrane depolarization during SA node cell action potential(GO:0086046) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 0.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.0 | 0.1 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.0 | 0.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.0 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 | 2.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.1 | GO:2000977 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil differentiation(GO:0030222) eosinophil fate commitment(GO:0035854) regulation of forebrain neuron differentiation(GO:2000977) |
| 0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.0 | 0.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 | 0.3 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 | 0.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 | 0.4 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
| 0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.6 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
| 0.0 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 | 0.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.0 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 | 0.2 | GO:0019541 | acetate metabolic process(GO:0006083) acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.0 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
| 0.0 | 0.1 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 | 0.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 | 0.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.0 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
| 0.0 | 0.1 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.7 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.0 | 0.0 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 | 0.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.0 | 0.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.0 | 0.3 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
| 0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.0 | 0.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.5 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 0.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.2 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.0 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.0 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.0 | 0.2 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
| 0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.0 | 0.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.5 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.2 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 | 0.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.0 | 0.0 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.0 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.0 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.0 | 0.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.1 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
| 0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 | 0.1 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
| 0.0 | 0.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
| 0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.2 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.8 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.0 | GO:1904396 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 | 0.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 19.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 2.5 | 4.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 2.4 | 7.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 2.3 | 9.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 2.0 | 26.1 | GO:0000796 | condensin complex(GO:0000796) |
| 2.0 | 5.9 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.9 | 5.7 | GO:0044609 | DBIRD complex(GO:0044609) |
| 1.9 | 16.9 | GO:0005683 | U7 snRNP(GO:0005683) |
| 1.8 | 9.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 1.7 | 5.2 | GO:0035101 | FACT complex(GO:0035101) |
| 1.7 | 10.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.5 | 12.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.5 | 4.5 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.5 | 4.4 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.4 | 8.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 1.4 | 16.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.3 | 10.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.3 | 3.9 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.3 | 9.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 1.3 | 5.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 1.3 | 3.8 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 1.3 | 8.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 1.2 | 18.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.2 | 18.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.2 | 2.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 1.2 | 3.6 | GO:0034455 | t-UTP complex(GO:0034455) |
| 1.1 | 6.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.0 | 6.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.0 | 4.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.0 | 2.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.0 | 12.5 | GO:0042555 | MCM complex(GO:0042555) |
| 1.0 | 8.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 1.0 | 3.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.9 | 4.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.9 | 8.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.9 | 14.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.9 | 3.6 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.9 | 6.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.9 | 9.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.9 | 2.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.9 | 2.7 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.9 | 4.4 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.9 | 3.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.9 | 11.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.9 | 6.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.9 | 2.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.8 | 11.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.8 | 5.6 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.8 | 2.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.8 | 4.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.8 | 5.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.8 | 8.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.8 | 14.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.8 | 10.3 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.8 | 2.3 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.8 | 10.8 | GO:0034464 | BBSome(GO:0034464) |
| 0.8 | 3.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.7 | 2.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.7 | 2.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.7 | 7.8 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.7 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.7 | 4.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.7 | 10.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.7 | 8.7 | GO:0034709 | methylosome(GO:0034709) |
| 0.7 | 2.0 | GO:0034657 | GID complex(GO:0034657) |
| 0.7 | 2.0 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.7 | 2.0 | GO:0008623 | CHRAC(GO:0008623) |
| 0.6 | 7.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.6 | 58.8 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.6 | 1.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.6 | 4.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.6 | 7.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.6 | 1.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.6 | 3.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.6 | 3.0 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.6 | 2.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.6 | 3.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.6 | 9.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.6 | 11.4 | GO:0000800 | lateral element(GO:0000800) |
| 0.6 | 4.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.6 | 14.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.6 | 3.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.5 | 3.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.5 | 1.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.5 | 9.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.5 | 11.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.5 | 42.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.5 | 4.7 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.5 | 2.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.5 | 2.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.5 | 1.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.5 | 1.5 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.5 | 5.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.5 | 5.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.5 | 1.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.5 | 7.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 4.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.5 | 7.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.5 | 19.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.5 | 1.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.5 | 3.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.5 | 3.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.5 | 5.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.5 | 1.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.5 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.4 | 12.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.4 | 12.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 4.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.4 | 2.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.4 | 5.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.4 | 28.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.4 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 2.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.4 | 1.2 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.4 | 3.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.4 | 19.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 3.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 2.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.4 | 3.9 | GO:0005638 | lamin filament(GO:0005638) |
| 0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.4 | 5.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.4 | 38.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.4 | 1.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.4 | 1.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.4 | 6.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.4 | 3.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.4 | 2.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.4 | 2.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.4 | 26.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.4 | 7.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.3 | 2.4 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.3 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 20.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.3 | 3.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.3 | 1.0 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.3 | 1.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.3 | 2.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 3.2 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
| 0.3 | 9.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.3 | 2.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 5.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.3 | 1.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 1.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.3 | 7.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.3 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.3 | 1.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 1.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.3 | 1.4 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.3 | 4.7 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 1.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 1.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 6.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.3 | 1.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.3 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 3.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.3 | 1.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 9.9 | GO:0000776 | kinetochore(GO:0000776) |
| 0.2 | 2.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 2.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.2 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.9 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 25.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.2 | 0.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.2 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 1.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.2 | 2.9 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.2 | 20.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 0.9 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.2 | 0.7 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.2 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.2 | 5.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.2 | 6.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.2 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 2.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 1.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 1.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 1.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 7.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 0.8 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 7.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.2 | 4.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.2 | 3.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 2.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.2 | 5.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 19.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 4.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 8.1 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 12.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 4.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.2 | 0.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 27.5 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.2 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 4.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 0.7 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 0.6 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.2 | 2.4 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 7.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.2 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 0.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 1.7 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 1.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 16.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.4 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.1 | 0.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 1.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 3.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.1 | 0.6 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 2.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 1.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 1.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 3.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 0.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.1 | 0.5 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 2.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.1 | 0.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.1 | 1.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 2.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 4.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 4.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 3.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 10.8 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 1.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.1 | 2.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 4.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 3.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 2.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 53.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 2.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 1.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 1.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 2.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 3.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 8.6 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 0.3 | GO:1902555 | endoribonuclease complex(GO:1902555) |
| 0.1 | 1.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 1.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.1 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 3.7 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.1 | GO:1902911 | protein kinase complex(GO:1902911) |
| 0.1 | 2.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 1.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 17.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 9.0 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 5.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.3 | GO:0071010 | prespliceosome(GO:0071010) |
| 0.1 | 1.5 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 1.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.3 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 1.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.3 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 2.0 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 29.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 30.5 | GO:0005813 | centrosome(GO:0005813) |
| 0.1 | 4.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.1 | 1.5 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 1.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.1 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.5 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.7 | GO:0099634 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 3.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 82.1 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 3.5 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 3.3 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 1.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 4.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.3 | GO:1990584 | cardiac myofibril(GO:0097512) cardiac Troponin complex(GO:1990584) |
| 0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 1.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.3 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.1 | 1.3 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 3.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 3.7 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 7.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.0 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.0 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.8 | GO:0005856 | cytoskeleton(GO:0005856) |
| 0.0 | 0.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.0 | 1.6 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
| 0.0 | 0.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 1.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.0 | 4.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
| 0.0 | 2.5 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.0 | 4.8 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.4 | GO:0044297 | cell body(GO:0044297) |
| 0.0 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 0.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.0 | 0.4 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.0 | 0.2 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 2.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.1 | GO:0070703 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
| 0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 1.4 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 1.2 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
| 0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 7.2 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 4.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.9 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 1.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 1.2 | GO:0005938 | cell cortex(GO:0005938) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 4.9 | GO:0005929 | cilium(GO:0005929) |
| 0.0 | 1.9 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.1 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 0.0 | GO:0071944 | cell periphery(GO:0071944) |
| 0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.0 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 1.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 27.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 4.7 | 14.1 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 4.1 | 12.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 3.8 | 22.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 3.3 | 13.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 2.5 | 10.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 2.4 | 7.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 2.4 | 9.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 2.1 | 2.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 2.0 | 13.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.8 | 5.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 1.7 | 16.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.5 | 6.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.5 | 1.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 1.5 | 4.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 1.4 | 8.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 1.4 | 7.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.4 | 1.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 1.4 | 12.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.4 | 4.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 1.3 | 8.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.3 | 6.7 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 1.3 | 10.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 1.3 | 8.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.3 | 5.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 1.3 | 3.9 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 1.3 | 2.6 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 1.3 | 3.9 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 1.3 | 1.3 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 1.3 | 3.8 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 1.2 | 3.7 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 1.2 | 12.0 | GO:0070990 | snRNP binding(GO:0070990) |
| 1.2 | 5.9 | GO:0002046 | opsin binding(GO:0002046) |
| 1.2 | 1.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 1.2 | 9.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 1.2 | 4.7 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 1.1 | 10.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 1.1 | 6.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 1.1 | 3.3 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 1.1 | 5.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.1 | 5.4 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 1.1 | 3.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 1.1 | 8.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 1.0 | 5.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 1.0 | 3.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 1.0 | 5.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.0 | 4.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 1.0 | 5.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.9 | 1.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.9 | 10.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.9 | 10.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.9 | 5.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.9 | 6.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.9 | 6.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.9 | 3.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.9 | 18.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.9 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.9 | 9.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.9 | 3.5 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.9 | 2.6 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.8 | 2.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.8 | 2.5 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.8 | 4.9 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.8 | 8.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.8 | 17.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.8 | 4.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.8 | 2.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.8 | 3.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.8 | 1.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.8 | 2.3 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.8 | 2.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.8 | 2.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.8 | 2.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.8 | 3.0 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.7 | 7.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.7 | 3.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.7 | 6.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.7 | 2.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.7 | 2.9 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.7 | 0.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.7 | 4.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.7 | 2.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.7 | 1.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.7 | 4.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.7 | 4.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.7 | 3.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.7 | 3.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.7 | 2.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.7 | 1.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.7 | 6.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.7 | 4.0 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.6 | 2.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.6 | 3.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.6 | 5.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.6 | 2.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.6 | 5.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.6 | 4.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.6 | 5.6 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.6 | 7.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.6 | 4.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.6 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.6 | 4.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.6 | 3.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.6 | 1.8 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.6 | 2.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.6 | 2.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.6 | 1.7 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 1.7 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.6 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.6 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.6 | 13.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.6 | 9.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.6 | 1.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.5 | 1.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.5 | 1.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.5 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.5 | 21.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.5 | 2.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.5 | 11.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.5 | 1.6 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.5 | 3.1 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.5 | 9.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.5 | 5.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.5 | 2.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.5 | 8.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.5 | 17.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.5 | 5.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.5 | 2.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.5 | 1.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.5 | 14.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.5 | 2.0 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.5 | 1.5 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.5 | 10.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 1.5 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.5 | 2.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.5 | 3.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.5 | 2.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.5 | 7.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.5 | 8.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.5 | 46.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.5 | 1.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.5 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 6.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.5 | 3.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.5 | 7.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.5 | 2.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.4 | 0.9 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.4 | 6.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.4 | 5.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 3.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.4 | 5.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.4 | 6.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.4 | 1.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.4 | 1.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.4 | 2.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 5.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.4 | 2.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.4 | 2.1 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.4 | 1.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.4 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.4 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.4 | 3.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 1.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.4 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.4 | 2.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 3.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.4 | 1.2 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.4 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.4 | 1.2 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 6.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.4 | 1.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.4 | 11.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 9.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.4 | 3.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.4 | 3.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.4 | 13.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.4 | 1.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.4 | 1.1 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.4 | 3.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.4 | 1.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.4 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.4 | 1.4 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 83.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.4 | 1.4 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.3 | 4.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 11.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.3 | 1.7 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.3 | 1.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.3 | 6.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.3 | 1.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.3 | 1.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 12.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.3 | 2.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 8.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.3 | 2.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.3 | 1.0 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.3 | 1.3 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.3 | 18.9 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
| 0.3 | 2.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 2.9 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.3 | 1.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 1.3 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.3 | 2.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.3 | 1.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.3 | 0.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.3 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 2.8 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 17.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.3 | 0.9 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.3 | 1.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.3 | 1.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.3 | 0.9 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.3 | 1.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 1.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 2.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.3 | 1.2 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.3 | 1.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.3 | 0.9 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.3 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.3 | 2.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.3 | 0.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.3 | 0.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 1.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 3.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.3 | 1.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.3 | 0.8 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 3.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 1.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.3 | 10.7 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.3 | 1.1 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.3 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 0.8 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.3 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 0.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.3 | 0.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 1.0 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.3 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.3 | 0.5 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.3 | 0.8 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.3 | 2.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.3 | 0.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 3.4 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 3.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.3 | 6.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.3 | 1.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.3 | 0.8 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
| 0.3 | 4.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.3 | 1.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 1.0 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.3 | 3.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 0.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 1.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.2 | 1.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 1.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 1.0 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.2 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 0.7 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 0.7 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.2 | 1.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 0.9 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.2 | 2.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 2.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 1.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 10.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 1.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.2 | 0.9 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 1.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 1.8 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.2 | 1.3 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 2.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 3.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 5.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 1.1 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.2 | 2.4 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 3.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 6.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 5.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 0.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 1.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 2.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 0.8 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 0.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.2 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 3.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.2 | 2.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 6.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.2 | 1.0 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.2 | 3.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 0.2 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 0.8 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.2 | 6.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 9.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 0.8 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.2 | 0.6 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.2 | 2.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 6.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 11.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 2.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 3.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 12.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 2.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 0.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.2 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.2 | 0.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.2 | 5.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 1.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 14.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 0.4 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.2 | 0.7 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.2 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 1.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.2 | 0.4 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.2 | 0.9 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.2 | 2.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 0.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.2 | 0.5 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.2 | 0.5 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.2 | 4.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.2 | 0.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.2 | 1.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.2 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.2 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 7.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 1.0 | GO:0016887 | ATPase activity(GO:0016887) |
| 0.2 | 0.7 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.2 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.2 | 0.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.2 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.2 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 4.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.2 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 0.8 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 1.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 3.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 2.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.2 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 4.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 0.5 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 2.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 2.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 5.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 3.0 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 0.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.2 | 3.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.2 | 6.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.2 | 4.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.2 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 3.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.2 | 1.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.2 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.2 | 1.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 2.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 4.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.4 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.1 | 1.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 6.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.7 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.1 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.4 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 0.4 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.1 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 1.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 1.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 5.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.4 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.1 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 1.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.1 | 2.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 13.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.4 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.1 | 1.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 5.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 2.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 0.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 2.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 1.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.7 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.1 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 15.4 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.1 | 0.6 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 14.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.5 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 0.5 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.1 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.1 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 3.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 1.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 1.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.3 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
| 0.1 | 1.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 4.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.1 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 3.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 0.3 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 1.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.1 | 0.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.1 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.1 | 1.5 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 0.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.1 | 0.9 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.1 | 1.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.5 | GO:0016661 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) melatonin binding(GO:1904408) |
| 0.1 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.1 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.1 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.9 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.1 | 1.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 5.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.3 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.3 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 0.5 | GO:0008047 | enzyme activator activity(GO:0008047) |
| 0.1 | 0.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.1 | 0.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 5.0 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 4.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.5 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.1 | 2.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.3 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.4 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.1 | 3.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 7.7 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 0.2 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.1 | 0.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.1 | 0.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 4.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.1 | 0.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.1 | 0.7 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 4.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 0.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.1 | 0.2 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.1 | 1.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 4.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 5.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 4.1 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 1.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 0.8 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 1.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.1 | 1.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 2.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.2 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 2.4 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 1.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 3.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 4.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 1.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 12.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 0.5 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 0.9 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.5 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 1.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 8.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.0 | 0.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 1.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.0 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 1.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
| 0.0 | 1.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 1.9 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 2.8 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 3.9 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.0 | 0.0 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.5 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.0 | 0.1 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 1.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.0 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.0 | 0.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) L-threonine ammonia-lyase activity(GO:0004794) |
| 0.0 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.0 | 1.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.0 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.0 | 2.3 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
| 0.0 | 0.0 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.0 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.0 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.0 | 4.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 0.0 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.0 | 0.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.0 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.1 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 4.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.0 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 1.0 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 2.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.0 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.0 | 0.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 2.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 2.4 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 85.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.9 | 78.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.8 | 2.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.6 | 1.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.5 | 4.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.4 | 1.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.4 | 29.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.3 | 8.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 4.2 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.2 | 9.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 7.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 5.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 6.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.2 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 6.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 11.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 5.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 6.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 6.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 6.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 3.9 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 3.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 7.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 4.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 7.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 3.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 5.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 4.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 7.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 3.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 2.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 3.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 2.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 4.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 2.4 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 31.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 1.5 | 19.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.4 | 64.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.0 | 37.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 1.0 | 19.0 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
| 1.0 | 26.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.7 | 24.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.7 | 13.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.7 | 11.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.7 | 19.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.7 | 25.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.7 | 2.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.6 | 89.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.6 | 2.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.6 | 25.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 0.6 | 11.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.6 | 5.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.6 | 6.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 10.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.5 | 18.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.5 | 10.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.5 | 9.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.5 | 10.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.4 | 32.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.4 | 18.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.4 | 7.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.4 | 6.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 10.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.4 | 14.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.4 | 28.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.4 | 9.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.3 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.3 | 23.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.3 | 19.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 5.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 4.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.3 | 4.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.3 | 0.6 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.3 | 12.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 8.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 1.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.3 | 13.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.3 | 6.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 8.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 7.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 6.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 0.9 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 3.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.2 | 4.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.2 | 6.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.2 | 2.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 5.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 2.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.2 | 4.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 14.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 1.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 10.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 6.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 6.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.2 | 1.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 7.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 7.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.2 | 9.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 5.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 7.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 16.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 4.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 14.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.1 | 1.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 7.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 4.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
| 0.1 | 10.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 3.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.1 | 6.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 6.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 2.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 6.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 7.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 0.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.1 | 1.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 3.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 3.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 3.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 2.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 16.5 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.1 | 6.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 3.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 4.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 3.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 1.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.0 | 2.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.0 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.0 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.0 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 1.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.0 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.0 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 1.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 1.7 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |